Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Gillespie

Showing results (391-400 of 527) with videos related to

Pageof 53
Sort By:
Eclinicalmedicine|February 19, 2025
R-index: a standardized representativeness metric for benchmarking diversity, equity, and inclusion in biopharmaceutical clinical trial developmentSpencer L James, Max Bourgognon, Patricia Pinto Vieira, et al.
Oncogene|May 22, 2001
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion frontC P Paweletz, L Charboneau, V E Bichsel, et al.
Journal of the National Cancer Institute|February 16, 2006
Gene promoter methylation in prostate tumor-associated stromal cellsJeffrey A Hanson, John W Gillespie, Amelia Grover, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2007
Risk factors for urinary complications after renal transplantationM J Englesbe, D A Dubay, B W Gillespie, et al.
The Journal of Trauma|February 1, 1987
Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn woundsG F Purdue, J L Hunt, R W Gillespie, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 6, 2007
Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS)Jennifer L Bragg-Gresham, Rachel B Fissell, Nancy A Mason, et al.
Neurourology and Urodynamics|June 22, 2019
A new outcome measure for LUTS: Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index-29 (LURN SI-29) questionnaireDavid Cella, Abigail R Smith, James W Griffith, et al.
Pharmacotherapy|February 11, 2022
A dose-escalation clinical trial of intranasal ketamine for uncontrolled cancer-related painVinita Singh, Theresa W Gillespie, Olabisi Lane, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 16, 2013
Estimating prevalence of CKD stages 3-5 using health system dataVahakn B Shahinian, Elizabeth Hedgeman, Brenda W Gillespie, et al.
Archives of Pathology & Laboratory Medicine|February 20, 2018
Reproducibility and Feasibility of Strategies for Morphologic Assessment of Renal Biopsies Using the Nephrotic Syndrome Study Network Digital Pathology Scoring SystemJarcy Zee, Jeffrey B Hodgin, Laura H Mariani, et al.
Pageof 53

Showing results (391-400 of 527) with videos related to

Sort By:
Pageof 53
Eclinicalmedicine|February 19, 2025
R-index: a standardized representativeness metric for benchmarking diversity, equity, and inclusion in biopharmaceutical clinical trial developmentSpencer L James, Max Bourgognon, Patricia Pinto Vieira, et al.
Oncogene|May 22, 2001
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion frontC P Paweletz, L Charboneau, V E Bichsel, et al.
Journal of the National Cancer Institute|February 16, 2006
Gene promoter methylation in prostate tumor-associated stromal cellsJeffrey A Hanson, John W Gillespie, Amelia Grover, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2007
Risk factors for urinary complications after renal transplantationM J Englesbe, D A Dubay, B W Gillespie, et al.
The Journal of Trauma|February 1, 1987
Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn woundsG F Purdue, J L Hunt, R W Gillespie, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 6, 2007
Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS)Jennifer L Bragg-Gresham, Rachel B Fissell, Nancy A Mason, et al.
Neurourology and Urodynamics|June 22, 2019
A new outcome measure for LUTS: Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index-29 (LURN SI-29) questionnaireDavid Cella, Abigail R Smith, James W Griffith, et al.
Pharmacotherapy|February 11, 2022
A dose-escalation clinical trial of intranasal ketamine for uncontrolled cancer-related painVinita Singh, Theresa W Gillespie, Olabisi Lane, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 16, 2013
Estimating prevalence of CKD stages 3-5 using health system dataVahakn B Shahinian, Elizabeth Hedgeman, Brenda W Gillespie, et al.
Archives of Pathology & Laboratory Medicine|February 20, 2018
Reproducibility and Feasibility of Strategies for Morphologic Assessment of Renal Biopsies Using the Nephrotic Syndrome Study Network Digital Pathology Scoring SystemJarcy Zee, Jeffrey B Hodgin, Laura H Mariani, et al.
Pageof 53